VP
venBio Partners Portfolio holdings
AUM
$115M
This Quarter Return
+97.61%
1 Year Return
-33.99%
3 Year Return
+221.07%
5 Year Return
+224.54%
10 Year Return
–
AUM
$1.13B
AUM Growth
+$1.13B
(+72%)
Cap. Flow
-$8.63M
Cap. Flow
% of AUM
-0.76%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
8
New
–
Increased
–
Reduced
1
Closed
1
Top Buys
No buys this quarter
Top Sells
| 1 |
Precision BioSciences
DTIL
|
$8M |
| 2 |
Apellis Pharmaceuticals
APLS
|
$636K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
ALX Oncology
ALXO
$62.7M
| $836M | 73.8% | 9,699,925 | – | – |
|
2
Harmony Biosciences
HRMY
$2.12B
| $127M | 11.18% | 3,504,624 | – | – |
|
3
Akero Therapeutics
AKRO
$3.74B
| $63.1M | 5.57% | 2,444,311 | – | – |
|
|
CMPI
4
DELISTED
Checkmate Pharmaceuticals, Inc. Common Stock
CMPI
| $53.6M | 4.73% | 3,673,374 | – | – |
|
|
5
Apellis Pharmaceuticals
APLS
$3.48B
| $28.1M | 2.48% | 490,471 -11,113 | -2% | -$636K |
|
|
MTCR
6
DELISTED
Metacrine, Inc. Common Stock
MTCR
| $24M | 2.12% | 3,059,123 | – | – |
|
|
VRNA
7
Verona Pharma
VRNA
$9.16B
| $1.39M | 0.12% | 199,075 | – | – |
|
|
8
Precision BioSciences
DTIL
$57.8M
| – | – | -1,298,191 | Closed | -$8M |
|